PH12015502477A1 - Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione - Google Patents
Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dioneInfo
- Publication number
- PH12015502477A1 PH12015502477A1 PH12015502477A PH12015502477A PH12015502477A1 PH 12015502477 A1 PH12015502477 A1 PH 12015502477A1 PH 12015502477 A PH12015502477 A PH 12015502477A PH 12015502477 A PH12015502477 A PH 12015502477A PH 12015502477 A1 PH12015502477 A1 PH 12015502477A1
- Authority
- PH
- Philippines
- Prior art keywords
- oxoquinazolin
- dione
- piperidine
- amino
- methyl
- Prior art date
Links
- RSNPAKAFCAAMBH-UHFFFAOYSA-N 3-(5-amino-2-methyl-4-oxoquinazolin-3-yl)piperidine-2,6-dione Chemical compound CC1=NC2=CC=CC(N)=C2C(=O)N1C1CCC(=O)NC1=O RSNPAKAFCAAMBH-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361818254P | 2013-05-01 | 2013-05-01 | |
| PCT/US2014/036083 WO2014179416A1 (en) | 2013-05-01 | 2014-04-30 | Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12015502477A1 true PH12015502477A1 (en) | 2016-02-22 |
Family
ID=50885008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12015502477A PH12015502477A1 (en) | 2013-05-01 | 2015-10-27 | Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US9067912B2 (https=) |
| EP (2) | EP3199532A1 (https=) |
| JP (2) | JP6490055B2 (https=) |
| KR (1) | KR20160003228A (https=) |
| CN (2) | CN107935994A (https=) |
| AR (1) | AR096165A1 (https=) |
| AU (2) | AU2014260011A1 (https=) |
| CA (1) | CA2910971A1 (https=) |
| CY (1) | CY1119525T1 (https=) |
| DK (1) | DK2991976T3 (https=) |
| ES (1) | ES2645944T3 (https=) |
| HR (1) | HRP20171535T1 (https=) |
| HU (1) | HUE034770T2 (https=) |
| LT (1) | LT2991976T (https=) |
| MX (1) | MX363652B (https=) |
| NZ (1) | NZ628322A (https=) |
| PH (1) | PH12015502477A1 (https=) |
| PL (1) | PL2991976T3 (https=) |
| PT (1) | PT2991976T (https=) |
| RS (1) | RS56565B1 (https=) |
| RU (1) | RU2015151359A (https=) |
| SG (1) | SG11201508836XA (https=) |
| SI (1) | SI2991976T1 (https=) |
| SM (1) | SMT201700513T1 (https=) |
| TW (1) | TW201536766A (https=) |
| WO (1) | WO2014179416A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME02420B (me) | 2006-09-26 | 2016-09-20 | Celgene Corp | 5-supstituirani derivati kinazolinona kao sredstva protiv raka |
| DK2683708T3 (da) | 2011-03-11 | 2018-01-29 | Celgene Corp | Faste former af 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidin-2,6-dion og farmaceutiske sammensætninger og anvendelser deraf |
| EP2892887B1 (en) | 2012-09-04 | 2020-07-15 | Celgene Corporation | Isotopologues of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2-6-dione and methods of preparation thereof |
| US10973822B2 (en) | 2015-07-02 | 2021-04-13 | Celgene Corporation | Combination therapy for treatment of hematological cancers and solid tumors |
| CN106083622B (zh) * | 2016-06-16 | 2018-06-19 | 常州齐晖药业有限公司 | 一种甲苯咪唑中间体3,4-二氨基二苯甲酮的制备方法 |
| WO2018165142A1 (en) * | 2017-03-07 | 2018-09-13 | Celgene Corporation | Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses |
| CN113101295A (zh) * | 2020-03-20 | 2021-07-13 | 上海疆云医疗健康科技有限公司 | 二苯乙烯类似物在治疗糖尿病肾脏疾病中的用途 |
| JP2024530782A (ja) * | 2021-09-02 | 2024-08-23 | シントン・ビー．ブイ． | オシメルチニブの製造方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009539878A (ja) * | 2006-06-08 | 2009-11-19 | アレイ バイオファーマ、インコーポレイテッド | キノリン化合物および使用方法 |
| ME02420B (me) * | 2006-09-26 | 2016-09-20 | Celgene Corp | 5-supstituirani derivati kinazolinona kao sredstva protiv raka |
| PH12013501837A1 (en) * | 2011-03-11 | 2013-11-18 | Celgene Corp | Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione in treatment of immune-related and inflammatory diseases |
| DK2683708T3 (da) * | 2011-03-11 | 2018-01-29 | Celgene Corp | Faste former af 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidin-2,6-dion og farmaceutiske sammensætninger og anvendelser deraf |
| EP2892887B1 (en) * | 2012-09-04 | 2020-07-15 | Celgene Corporation | Isotopologues of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2-6-dione and methods of preparation thereof |
| JP6359563B2 (ja) * | 2013-01-14 | 2018-07-18 | デュートルクス・リミテッド・ライアビリティ・カンパニーＤｅｕｔｅＲｘ， ＬＬＣ | ３−（５置換−４−オキソキナゾリン−３（４ｈ）−イル）−３−ジュウテロピペリジン−２，６−ジオン誘導体 |
-
2014
- 2014-04-30 SM SM20170513T patent/SMT201700513T1/it unknown
- 2014-04-30 US US14/266,448 patent/US9067912B2/en not_active Expired - Fee Related
- 2014-04-30 CN CN201810004591.8A patent/CN107935994A/zh active Pending
- 2014-04-30 ES ES14728381.6T patent/ES2645944T3/es active Active
- 2014-04-30 PL PL14728381T patent/PL2991976T3/pl unknown
- 2014-04-30 EP EP17161076.9A patent/EP3199532A1/en not_active Withdrawn
- 2014-04-30 DK DK14728381.6T patent/DK2991976T3/da active
- 2014-04-30 WO PCT/US2014/036083 patent/WO2014179416A1/en not_active Ceased
- 2014-04-30 CA CA2910971A patent/CA2910971A1/en not_active Abandoned
- 2014-04-30 TW TW103115643A patent/TW201536766A/zh unknown
- 2014-04-30 HR HRP20171535TT patent/HRP20171535T1/hr unknown
- 2014-04-30 RS RS20171105A patent/RS56565B1/sr unknown
- 2014-04-30 SG SG11201508836XA patent/SG11201508836XA/en unknown
- 2014-04-30 AR ARP140101806A patent/AR096165A1/es unknown
- 2014-04-30 PT PT147283816T patent/PT2991976T/pt unknown
- 2014-04-30 KR KR1020157034184A patent/KR20160003228A/ko not_active Withdrawn
- 2014-04-30 NZ NZ628322A patent/NZ628322A/en not_active IP Right Cessation
- 2014-04-30 EP EP14728381.6A patent/EP2991976B1/en active Active
- 2014-04-30 LT LTEP14728381.6T patent/LT2991976T/lt unknown
- 2014-04-30 MX MX2015015073A patent/MX363652B/es unknown
- 2014-04-30 SI SI201430431T patent/SI2991976T1/sl unknown
- 2014-04-30 JP JP2016511825A patent/JP6490055B2/ja not_active Expired - Fee Related
- 2014-04-30 RU RU2015151359A patent/RU2015151359A/ru unknown
- 2014-04-30 AU AU2014260011A patent/AU2014260011A1/en not_active Abandoned
- 2014-04-30 HU HUE14728381A patent/HUE034770T2/hu unknown
- 2014-04-30 CN CN201480038438.7A patent/CN105377831B/zh not_active Expired - Fee Related
-
2015
- 2015-06-10 US US14/736,146 patent/US9266858B2/en not_active Expired - Fee Related
- 2015-09-24 US US14/864,614 patent/US9303014B2/en not_active Expired - Fee Related
- 2015-10-27 PH PH12015502477A patent/PH12015502477A1/en unknown
-
2017
- 2017-02-13 AU AU2017200965A patent/AU2017200965A1/en not_active Abandoned
- 2017-10-26 CY CY20171101119T patent/CY1119525T1/el unknown
-
2018
- 2018-12-06 JP JP2018229189A patent/JP2019069958A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015502477A1 (en) | Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione | |
| MA39749A (fr) | Dérivés de pipéridine-dione | |
| EA201401054A1 (ru) | N-циклиламиды в качестве нематоцидов | |
| IN2015DN00845A (https=) | ||
| PH12015500275A1 (en) | Salts and solid forms of (s)-3-(4-((4-morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same | |
| WO2013098833A3 (en) | Processes and intermediates for preparing rivaroxaban | |
| TW201144301A (en) | Processes for preparing linezolid | |
| SG11201600996UA (en) | Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyloxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione | |
| NZ712341A (en) | A crystalline form of an anxiolytic compound | |
| MA40312A (fr) | Composition pharmaceutique orale d'isotrétinoïne | |
| MA39877A (fr) | Formes solides d'un composé pharmaceutiquement actif | |
| WO2013008253A3 (en) | Imatinib formulations | |
| EP3227306A4 (en) | Process for the preparation of tert-butyl 4-((2s,5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate and analogs thereof | |
| TW201612142A (en) | Process for preparing 3-chloro-2-vinylphenol | |
| PH12019550212B1 (en) | Process for the preparation of pirlindole enantiomers and its salts | |
| WO2014049552A3 (en) | Process for the preparation of rivaroxaban | |
| WO2014188334A3 (en) | Process for preparation of alogliptin | |
| TH1501006617A (th) | การสังเคราะห์ 3-(5อะมิโน-2-เมธิล-4-ออกโซควินาโซลิน-3(4h)-อิล)ไพเพอริดีน-2,6-ไดโอน | |
| IN2013CH04981A (https=) | ||
| IN2013CH05395A (https=) | ||
| PH12016501982A1 (en) | NEW ASSOCIATION BETWEEN 8-CYCLOPROPYL-3-[2-(3-FLUOROPHENYL)ETHYL]-7,8-DIHYDRO-3H-[1,3]OXAZINO[6,5-g][1,2,3]BENZOTRIAZINE-4,9-DIONE AND AN ACETYLCHOLINESTERASE INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
| IN2012DN03169A (https=) | ||
| WO2014061004A3 (en) | Process for the preparation of vilazodone or pharmaceutically acceptable salt thereof |